Fumaric Acid: study protocols
2 study groups say how much Fumaric Acid participants took a day. These are the doses the studies gave. They are not a recommendation.
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
None of these 2 study groups took Fumaric Acid with anything else.
2 study groups
| Study | |||
|---|---|---|---|
| Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm(®) - and placebo-controlled trial (BRIDGE) 2017 · Fumaderm · Adults with moderate-to-severe chronic plaque psoriasis | 720 mg | 16 weeks | 273 |
| Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm(®) - and placebo-controlled trial (BRIDGE) 2017 · LAS41008 · Adults with moderate-to-severe chronic plaque psoriasis | 720 mg | 16 weeks | 267 |